Highlights
ASX: BD1       BARD1 LIFE SCIENCES LIMITED
Last Price Today's Change   Day's Range   Trading Volume
0.052   +0.005 (10.64%)  0.047 - 0.052  8,901,579

Overview

 
Avg Volume (4 weeks):9,118,615
4 Weeks Range:0.034 - 0.054
4 Weeks Price Volatility (%):
90.00%
52 Weeks Range:0.013 - 0.075
52 Weeks Price Volatility (%):
62.90%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

BARD1 Life Sciences Ltd is an Australia-based life sciences company. The Company is engaged in developing diagnostics and therapeutics for unmet needs in cancer. Its proprietary BARD1 Technology is based on BARD1, a potent tumour suppressor in healthy individuals and important tumour biomarker in cancer. Its lead product the BARD1 Lung Cancer Test is a non-invasive blood test in development for early detection of lung cancer. It is also engaged in researching a pipeline of potential diagnostic and therapeutic products for multiple cancers. The Company's pipeline also includes BARD1 Ovarian Cancer Test and BARD1 Ribonucleic Acid (RNA) Test.

  Be the first to like this.
 


 

519  671  625  2558 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 GTG 0.006+0.001 
 MEB 0.011-0.002 
 MLX 0.185+0.01 
 SCG 3.85-0.02 
 SIQ 11.25-0.85 
 CL8 0.014+0.005 
 NVO 0.0150.00 
 SRO 0.0020.00 
 88E 0.0140.00 
 AUZ 0.029+0.002 
Partners & Brokers